H Lundbeck A/S (HLUYY) Downgraded by Deutsche Bank AG

Deutsche Bank AG downgraded shares of H Lundbeck A/S (OTC:HLUYY) from a hold rating to a sell rating in a research note issued to investors on Friday morning, StockTargetPrices.com reports.

Separately, Jefferies Group LLC lowered shares of H Lundbeck A/S from a buy rating to a hold rating in a research note on Wednesday, April 12th.

Shares of H Lundbeck A/S (OTC:HLUYY) opened at 59.97 on Friday. H Lundbeck A/S has a 52-week low of $31.00 and a 52-week high of $61.72. The firm has a 50-day moving average of $57.24 and a 200-day moving average of $49.07. The stock has a market cap of $11.83 billion, a P/E ratio of 46.92 and a beta of 0.31.

ILLEGAL ACTIVITY NOTICE: “H Lundbeck A/S (HLUYY) Downgraded by Deutsche Bank AG” was published by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/h-lundbeck-as-hluyy-downgraded-by-deutsche-bank-ag/1464896.html.

About H Lundbeck A/S

H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia.